IMMUNOGEN SAYS LOSS IN LINE WITH PREDICTIONImmunoGen Inc. (NASDAQ: IMGN) of Cambridge, Mass., saidthat second-quarter results, including a 17 percent larger loss,"met our expectations precisely. The company continues toutilize its funds in a manner which will allow us to achieve ourcommercial objectives in the projected time frame," saidMitchell Sayare, ImmunoGen's president and chief executiveofficer.

Second quarter ended Dec. 31(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 186 223 -17Net income (loss) (2,849) (2,086) -37Net income per share (loss) (.45) (.38) -18Outstanding shares 6,340 5,441 +17

AGOURON'S LOSS GROWS IN SECOND QUARTER

Agouron Pharmaceuticals Inc. (NASDAQ:AGPH) of La Jolla, Calif.,said increased second-quarter revenues reflected greatercontract revenues from Eli Lilly & Co. Per-share results reflectthe issuance of 46,884 common shares to preferredshareholders last Oct. 18.

Second quarter ended Dec. 31(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 1,346 822 +64Net income (loss) (1,612) (1,352) -19Net income per share (loss) (.34) (.34) sameOutstanding shares 4,737 3,954 +20

ESCAGENETICS REPORTS MUCH DEEPER LOSS

Escagenetics Corp. (ASE:ESN) of San Carlos, Calif., said a sharpdecline third-quarter revenues was primarily due to a changein the sale of corn, which was recorded in last year's thirdquarter and is expected this year in the fourth quarter.

Third quarter ended Dec. 31(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 761 1,536 -50Net income (loss) (1,055) (533) -98Net income per share (loss) (.28) (.14) -100Outstanding shares 3,709 3,682 negl.

SYNTRO REDUCES FIRST-QUARTER LOSS

Syntro Corp. (NASDAQ:SYNT) of Lenexa, Kan., said its 49 percentsmaller first-quarter loss -- the smallest quarterly loss in threeyears -- reflects continued progress toward profitability.

First quarter ended Dec. 31(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 1,054 717 +47Net income (loss) (288) (564) +49Net income per share (loss) (.03) (.06) +50Outstanding shares 9,563 n.a. n.a.

(c) 1997 American Health Consultants. All rights reserved.